X Bioscience PCL (BKK:XBIO)

X Bioscience PCL Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,215	179	1,030	732	1,612	3,532
Market Cap Growth	426.55%	-82.67%	40.78%	-54.60%	-54.38%	7.16%
Enterprise Value	1,457	521	1,408	1,116	2,451	3,856
Last Close Price	0.10	0.09	0.86	1.15	3.21	7.03
PS Ratio	9.37	1.38	3.23	2.35	4.68	13.91
PB Ratio	5.44	0.80	1.25	4.00	15.72	5.25
P/TBV Ratio	54.31	7.98	-	-	-	-
EV/Sales Ratio	11.24	4.02	4.41	3.58	7.11	15.18
Debt / Equity Ratio	1.08	1.08	0.43	2.27	4.61	0.70
Debt / EBITDA Ratio	-	-	-	-	-	25.74
Net Debt / Equity Ratio	1.06	1.06	0.37	2.12	4.46	0.66
Net Debt / EBITDA Ratio	-0.54	-0.54	-1.37	-3.78	-2.41	-32.63
Net Debt / FCF Ratio	-2.99	-2.99	-5.59	-2.91	-1.57	-2.08
Asset Turnover	0.13	0.13	0.30	0.43	0.34	0.20
Inventory Turnover	10.88	10.88	19.39	16.08	7.15	4.58
Quick Ratio	0.05	0.05	0.21	0.13	0.07	0.11
Current Ratio	0.93	0.93	0.25	0.17	0.12	0.22
Return on Equity (ROE)	-86.14%	-86.14%	-51.88%	-103.40%	-85.26%	-12.32%
Return on Assets (ROA)	-28.06%	-28.06%	-14.58%	-10.46%	-17.52%	-4.83%
Return on Invested Capital (ROIC)	-82.74%	-57.04%	-29.47%	-21.30%	-33.84%	-9.06%
Return on Capital Employed (ROCE)	-160.20%	-160.20%	-25.60%	-38.50%	-116.60%	-11.70%
Earnings Yield	-38.59%	-262.59%	-25.26%	-20.16%	-35.74%	-7.83%
FCF Yield	-6.49%	-44.18%	-5.32%	-18.26%	-18.07%	-6.02%
Buyback Yield / Dilution	-118.20%	-118.20%	-46.88%	-7.78%	-	-19.79%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.